3B FUTURE Health Fund is an institutional investor (Conventional VCs) founded in 2016 and headquartered in Monte Carlo, Monaco. Helsinn Investment Fund is an early-stage focused venture capital investment company. Geographies of interest include Europe and the US. Typically invests in life sciences startups operating in sectors such as Biotech, Diagnostic and Medical Devices. Top investments include GreenBone, OncoResponse, QuantuMDx. Notable portfolio companies: GreenBone, OncoResponse, QuantuMDx.

Stage

pre-Series A, Series A, early-stage, clinical development, pre-Series A, Series A, early-stage, clinical development

Check size

up to $12M per company

HQ

Monte Carlo, Monaco

Founded

2016

Website

http://helsinninvestmentfund.com

LinkedIn

https://linkedin.com/company/sapphire-capital-partners-llp

Twitter

https://twitter.com/sapphirecap

What they look for

US, Europe, Israel-based; first-in-class assets; experienced management teams; strong investor syndicate; high unmet patient needs; solid IP; shares core values of quality, integrity, respect

Preparing to pitch 3B FUTURE Health Fund?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.